Trial intelligence / Profile preview

Safety of NeoRecormon in Solid Tumors with Platinum-Induced Anemia

NCT02554942Phase 4Completed

Sponsor
Roche
Start
Jun 2004
Primary completion
Sep 2005
Modality
Erythropoietins, Colony Stimulating Factors
Countries
1
01

Overview

A Phase 4 trial of epoetin beta in anemia, sponsored by Roche. Started Jun 2004; status: completed.

02

Drugs

epoetin beta
03

Conditions

anemia

Beyond the preview

Go deeper on NCT02554942.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02554942.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call